Site~Rite Halcyon Diagnostic Ultrasound System

K170870 · Chison Medical Imaging Co., Ltd. · IYN · Jul 6, 2017 · Radiology

Device Facts

• Record ID: K170870
• Device Name: Site~Rite Halcyon Diagnostic Ultrasound System
• Applicant: Chison Medical Imaging Co., Ltd.
• Product Code: IYN · Radiology
• Decision Date: Jul 6, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 892.1550
• Device Class: Class 2
• Attributes: Pediatric

Intended Use

The device is a general-purpose ultrasonic imaging instrument intended for use by a qualified clinician for evaluation of Fetal/OB, Abdominal (GYN & Urology), Pediatric, Small Organ (breast, testes, thyroid), Cardiac (Adult & Pediatric), Peripheral Vascular, Vascular Access, Musculo-skeletal Conventional & Superficial.

Device Story

Compact, portable ultrasound system; hand-carried console with docking station/mobile cart. Inputs: interchangeable electronic-array transducers (linear, convex, phased). Processing: digital acquisition/processing via Linux OS; B-Mode (including Tissue Harmonic Imaging), M-Mode, PW Doppler, Color Doppler, or combined modes. Output: real-time ultrasound images/flow analysis on 10-inch color LED display. Operated by clinicians in clinical settings. Touch-sensitive screen interface for control/input. Benefits: portable diagnostic imaging for various clinical applications; supports biopsy guidance (2D).

Clinical Evidence

No clinical testing was required. Bench testing included electrical, mechanical, thermal, and electromagnetic compatibility safety, biocompatibility, and acoustic output measurements conforming to IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, ISO 10993-1, and NEMA UD2/UD3 standards.

Technological Characteristics

Compact ultrasound console; 10-inch color LED display; Linux OS. Supports linear, convex, and phased array transducers. Modes: B, M, PW Doppler, Color Doppler, PDI, DPD, Tissue Harmonic Imaging, Trapezoidal, Compound Imaging. Connectivity: docking station. Safety: IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, ISO 10993-1, NEMA UD2, NEMA UD3.

Indications for Use

Indicated for qualified clinicians to perform diagnostic ultrasound imaging or fluid flow analysis in Fetal/OB, Abdominal (GYN & Urology), Pediatric, Small Organ (breast, testes, thyroid), Cardiac (Adult & Pediatric), Peripheral Vascular, Vascular Access, and Musculo-skeletal (conventional & superficial) applications.

Regulatory Classification

Identification

An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Predicate Devices

• SonoTouch Series Diagnostic Ultrasound Systems (K121867)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of three human profiles facing right, stacked on top of each other. The profiles are rendered in black and have a flowing, interconnected design. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the profiles.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 6, 2017 CHISON MEDICAL IMAGING CO., LTD. Mr. OIFEI LIU REGULATORY AFFAIRS MANAGER NO.228. CHANGJIANG EAST ROAD, BLOCK 51 AND 53. PHASE 5 INDUSTRIAL PARK, SHUOFANG, New District, WUXI 214142 CHINA

Re: K170870

Trade/Device Name: Site~rite Halcyon Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed Doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: May 25, 2017 Received: May 30, 2017

Dear Qifei Liu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Michael D. O'Hara
For

Robert Ochs Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

#### Indications for Use

510(k) Number (if known) K1708070

Device Name

Site~Rite Halcyon Diagnostic Ultrasound System

Type of Use (Select one or both, as applicable)

Indications for Use (Describe)

The device is a general-purpose ultrasonic imstrument intended for use by a qualified clinician for evaluation of Fetal/OB, Abdominal (GYN & Urology), Pediatric, Small Organ (breast, testes, thyroid), Cardiac (Adult & Pediatric), Peripheral Vascular, Vascular Access, Musculo-skeletal Conventional & Superficial.

| <span> <span style="text-decoration: underline;"></span>Prescription Use (Part 21 CFR 801 Subpart D) </span> | <span>Over-The-Counter Use (21 CFR 801 Subpart C)</span> |
|--------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|
|--------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------|

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

***DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.***

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

[e-mail]

{3}------------------------------------------------

## Diagnostic Ultrasound Indications For Use

#### System: Site~Rite Halcyon Diagnostic Ultrasound System

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application | Mode of Operation | | | | | | | | |
|---------------------------|------------------------------------|---|---|---------------|---------------|------------------|------------------|-------------------|-------|
| General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PW<br>Doppler | CW<br>Doppler | Color<br>Doppler | Power<br>Doppler | Combined<br>Modes | Other |
| Ophthalmic | Ophthalmic | | | | | | | | |
| Fetal Imaging &<br>Other | Fetal | N | N | N | N | N | N | N | 3,4 |
| | Abdominal | N | N | N | N | N | N | N | 3,4 |
| | Intra-operative (Specify) | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | |
| | Laparoscopic | | | | | | | | |
| | Pediatric | N | N | N | N | N | N | N | 3,4 |
| | Small Organ[1] (Specify) | N | N | N | N | N | N | N | 3,4 |
| | Neonatal Cephalic | | | | | | | | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | N | N | N | N | N | N | N | 3,4 |
| | Musculo-skeletal<br>(Superficial) | N | N | N | N | N | N | N | 3,4 |
| | Other (Urology) | N | N | N | N | N | N | N | 3,4 |
| | Other (OB/GYN) | N | N | N | N | N | N | N | 3,4 |
| Cardiac | Cardiac Adult | N | N | N | N | N | N | N | 3,4 |
| | Cardiac Pediatric | N | N | N | N | N | N | N | 3,4 |
| Peripheral Vessel | Peripheral vessel | N | N | N | N | N | N | N | 3,4 |
| Other | Vascular Access | N | N | N | N | N | N | N | 3,4 |

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PW ,B/CFM/PW

2. Small Organ: thyroid, testes, breast

3. Includes guidance of biopsy (2D)

4. Tissue Harmonic Imaging

× Over-The-Counter Use Prescription Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health

{4}------------------------------------------------

#### System: Site~Rite Halcyon Diagnostic Ultrasound System Transducer: C3

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application | Mode of Operation | | | | | | | | |
|---------------------------|------------------------------------|---|---|---------------|---------------|------------------|------------------|-------------------|-------|
| General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PW<br>Doppler | CW<br>Doppler | Color<br>Doppler | Power<br>Doppler | Combined<br>Modes | Other |
| Ophthalmic | Ophthalmic | | | | | | | | |
| Fetal Imaging &<br>Other | Fetal | N | N | N | | N | N | N | 3,4 |
| | Abdominal | N | N | N | | N | N | N | 3,4 |
| | Intra-operative (Specify) | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | |
| | Laparoscopic | | | | | | | | |
| | Pediatric | | | | | | | | |
| | Small Organ[1] (Specify) | | | | | | | | |
| | Neonatal Cephalic | | | | | | | | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | | | | | | | | |
| | Musculo-skeletal<br>(Superficial) | | | | | | | | |
| | Other (Urology) | N | N | N | | N | N | N | 3,4 |
| | Other (OB/GYN) | N | N | N | | N | N | N | 3,4 |
| Cardiac | Cardiac Adult | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | |
| Peripheral Vessel | Peripheral vessel | | | | | | | | |

N = new indication; P = previously cleared by FDA; Note : 1. Combined modes are B/M, B/CFM , B/PW, B/CFM/PW E = added under this appendix

2. Small Organ: thyroid, testes, breast

3. Includes guidance of biopsy (2D)

4. Tissue Harmonic Imaging

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)

{5}------------------------------------------------

#### System: Site~Rite Halcyon Diagnostic Ultrasound System Transducer: L7SVA

| Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | |
|--------------------------------------------------------------------------------------------------|--|--|--|
| | | | |

| Clinical Application | Mode of Operation | | | | | | | | |
|---------------------------|------------------------------------|---|---|---------------|---------------|------------------|------------------|-------------------|-------|
| General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PW<br>Doppler | CW<br>Doppler | Color<br>Doppler | Power<br>Doppler | Combined<br>Modes | Other |
| Ophthalmic | Ophthalmic | | | | | | | | |
| Fetal Imaging &<br>Other | Fetal | | | | | | | | |
| | Abdominal | | | | | | | | |
| | Intra-operative (Specify) | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | |
| | Laparoscopic | | | | | | | | |
| | Pediatric | N | N | N | N | N | N | N | 3,4 |
| | Small Organ [1] (Specify) | N | N | N | N | N | N | N | 3,4 |
| | Neonatal Cephalic | | | | | | | | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | N | N | N | N | N | N | N | 3,4 |
| | Musculo-skeletal<br>(Superficial) | N | N | N | N | N | N | N | 3,4 |
| | Other (Urology) | | | | | | | | |
| | Other (OB/GYN) | | | | | | | | |
| Cardiac | Cardiac Adult | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | |
| Peripheral Vessel | Peripheral vessel | N | N | N | N | N | N | N | 3,4 |
| Other | Vascular Access | N | N | N | N | N | N | N | 3,4 |

P = previously cleared by FDA; N = new indication; Note : 1. Combined modes are B/M, B/CFM , B/PW ,B/CFM/PW

2. Small Organ: thyroid, testes, breast

3. Includes guidance of biopsy (2D)

4. Tissue Harmonic Imaging

Prescription Use _ Over-The-Counter Use × AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

(Division Sign Off) Division of Radiological Health

{6}------------------------------------------------

#### System: Site~Rite Halcyon Diagnostic Ultrasound System Transducer: P3

510(k)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application | Mode of Operation | | | | | | | | |
|---------------------------|------------------------------------|---|---|---------------|---------------|--------------------------|------------------|-------------------|-------|
| General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PW<br>Doppler | CW<br>Doppler | Color<br>Doppler Doppler | Power<br>Doppler | Combined<br>Modes | Other |
| Ophthalmic | Ophthalmic | | | | | | | | |
| Fetal Imaging & | Fetal | | | | | | | | |
| Other | Abdominal | N | N | N | | N | N | N | 3,4 |
| | Intra-operative (Specify) | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | |
| | Laparoscopic | | | | | | | | |
| | Pediatric | | | | | | | | |
| | Small Organ[1] (Specify) | | | | | | | | |
| | Neonatal Cephalic | | | | | | | | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | | | | | | | | |
| | Musculo-skeletal<br>(Superficial) | | | | | | | | |
| | Other (Urology) | | | | | | | | |
| | Other (OB/GYN) | | | | | | | | |
| Cardiac | Cardiac Adult | N | N | N | | N | N | N | 3,4 |
| | Cardiac Pediatric | N | N | N | | N | N | N | 3,4 |
| Peripheral Vessel | Peripheral vessel | | | | | | | | |

N = new indication; P = previously cleared by FDA;

Note : 1. Combined modes are B/M, B/CFM , B/PW ,B/CFM/PW

2. Small Organ: thyroid, testes, breast 3. Includes guidance of biopsy (2D)

4. Tissue Harmonic Imaging

E = added under this appendix

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)

{7}------------------------------------------------

# 510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:

### 1. Submitter:

| Submitter: | Chison Medical Imaging Co., Ltd. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Address: | No.228, ChangJiang East Road,Block 51 and 53,<br>Phase 5 Industrial Park, ShuoFang, New District,<br>Wuxi 214142, China<br>No.9 Xin Hui Huan Road, New District ,WuXi P.R.China |
| Contact: | Mr. Liu Qifei |
| Tel: | [phone] |
| Fax: | [phone] |
| Date Prepared: | June 15, 2016 |

### 2. Device :

Trade Name: Site~Rite Halcyon Diagnostic Ultrasound System

Common Name: Diagnostic Ultrasound System with Accessories

Classification: Regulatory Class: II

Review Category: Tier II

| Classfication Name | 21 CFR Section | Product Code |
|------------------------------------------|----------------|--------------|
| Ultrasonic pulsed doppler imaging system | 892.1550 | 90-IYN |
| Ultrasonic pulsed echo imaging system | 892.1560 | 90-IYO |
| Diagnostic ultrasonic transducer | 892.1570 | 90-ITX |

### 3. Predicate Device(s):

SonoTouch Series Diagnostic Ultrasound Systems 510(k) Number: K121867

### 4. Device Description:

The Site -Rite Halcyon device is a compact and extremely portable ultrasound system consisting of a hand-carried console with the ability to dock it with a Docking station or mobile Docking cart.The primary means of control is graphical user interface implemented by a touch sensitive screen over the color LED display providing additional command input and keyboard entry. It utilizes interchangeable electronic-array transducers operating B-Mode (including Tissue Harmonic Imaging), M-Mode, Pulsed (PW) Doppler Mode, Color Doppler Mode, or a combination of these modes. with digital acquisition, processing and display capability operating under a Linux OS. Powered by an integrated battery in the docking station , the Site~Rite Halcyon is used primarily where portability, size and convenience are essential.

{8}------------------------------------------------

#### 5. Indications for Use:

The device is a general-purpose ultrasonic imaging instrument intended for use by a qualified clinician for evaluation of Fetal/OB, Abdominal (GYN & Urology), Pediatric, Small Organ (breast, testes, thyroid), Cardiac (Adult & Pediatric), Peripheral Vascular, Vascular Access, Musculo-skeletal Conventional & Superficial

#### 6. Summary of Non-Clinical Tests:

The Site~Rite Halcyon Diagnostic Ultrasound System has been evaluated for electrical, mechanical, thermal and electromagnetic compatibility safety, biocompatibility and acoustic output.

The device has been found to conform to applicable medical device safety standards in regards to thermal, mechanical and electrical safety as well as biocompatibility.

IEC 60601-1: 2005 Medical Electrical Equipment - Part 1: General Requirements for Safetv

IEC 60601-1-2: 2014 Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests.

IEC 60601-2-37: 2007 Medical electrical equipment - Part 2-37: Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment.

NEMA UD 2-2004, Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment Version 3.

NEMA UD3: 2004 Standards for Real-time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment

ISO 10993-1:2009 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

### 7. Clinical Test:

No clinical testing was required.

### 8. Comparison to Predicate Device:

#### Table 1 Substantial Equivalence Comparison

| | Predicate Device | Submission Device | |
|-------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|
| Product<br>Name | SonoTouch Series<br>Diagnostic Ultrasound<br>Systems | Site~Rite Halcyon Diagnostic<br>Ultrasound System | Remark |
| Indications<br>for Use | Fetal/OB;<br>Abdominal (GYN & Urology);<br>Pediatric; | Fetal/OB;<br>Abdominal (GYN & Urology);<br>Pediatric; | SE<br>Analysis<br>1 |
| | | | |
| | Small Omgan(breast, testes,<br>thyroid); | Small Omgan(breast, testes,<br>thyroid); | |
| | Cardiac (adult & pediatric); | Cardiac (adult & pediatric); | |
| | Peripheral Vascular; | Peripheral Vascular;<br>Vascular Access; | |
| | Musculo-skeletal Conventional &<br>Superficial; | Musculo-skeletal Conventional &<br>Superficial. | |
| | Transrectal;<br>Transvaginal. | | |
| Design | Based on an embedded Linux<br>operating system. | Based on an embedded Linux<br>operating system. | |
| | Autocorrelation for color<br>processing and FFT for pulse | Autocorrelation for color processing<br>and FFT for pulse | Same |
| | Supporting Linear, Curve , and<br>Phase array probes . | Supporting Linear, Curve , and<br>Phase array probes . | |
| | Cine play back capability<br>Image file archive | Cine play back capability<br>Image file archive | |
| Operation<br>Controls | B-Mode | B-Mode | Same |
| | B/M Acoustic Output: 0-10, 1 step | B/M Acoustic Output: 0-10, 1 step | |
| | Focus Number: 4 steps | Focus Number: 4 steps | Same |
| | High Density: 0, 1 | High Density: 0, 1 | Same |
| | Frame Average: 0-7 steps | Frame Average: 0-7 steps | Same |
| | Edge Enhance: 0-7steps | Edge Enhance: 0-7steps | Same |
| | B Color Map: 0-31steps | B Color Map: 0-31steps | Same |
| | Gain: 0 - 255 steps | Gain: 0 - 255 steps | Same |
| | Dynamic Range: 30 - 90dB | Dynamic Range: 30 - 90dB | Same |
| | THI: on/off | THI: on/off | Same |
| | Depth: 1.5 - 24.6 cm | Depth: 1.5 - 24.6 cm | Same |
| | Color Flow Mode | Color Flow Mode | Same |
| | CF/PDI Focus Depth | CF/PDI Focus Depth | |
| | Frame Average: 0-7 steps | Frame Average: 0-7 steps | Same |
| | PRF: 0-15 steps | PRF: 0-15 steps | Same |
| | Gain: 0 - 255 steps | Gain: 0 - 255 steps | Same |
| | Wall Filter: 0-3 steps | Wall Filter: 0-3 steps | Same |
| | Angle:20,0,-20 | Angle:20,0,-20 | Same |
| | CF/PDI Focal Number: 1 | CF/PDI Focal Number: 1 | Same |
| | Color Map: 0-8 steps | Color Map: 0-8 steps | Same |
| | Color Threshold: 0-15 steps | Color Threshold: 0-15 steps | Same |
| | M-Mode | M-Mode | Same |
| | Sweep Speed: 4 steps | Sweep Speed: 4 steps | |
| | M Color: 4 types | M Color: 4 types | Same |
| | M Gain: 0 - 255 steps | M Gain: 0 - 255 steps | Same |
| | PW-Mode | PW-Mode | Same |
| | Doppler Gain:0~255 | Doppler Gain:0~255 | |
| | PRF:0~15 | PRF:0~15…